Mild cognitive impairment (MCI) is an early phase of cognitive decline signalling the beginning of severe neurological diseases. Carotid intima-media thickness (cIMT) has shown some…
Objectives Approximately 30% of patients with aneurysmal subarachnoid hemorrhage (aSAH) develop delayed cerebral ischemia (DCI). DCI is associated with increased mortality and persistent neurological deficits.…
Abstract Objectives Fatigue and walking impairment are disabling symptoms of multiple sclerosis (MS). We investigated the effects of progressive aerobic exercise (PAE) on fatigue, walking,…
Objectives To evaluate the usefulness of quantitative electroencephalography (qEEG) in the analysis of baseline activity in patients with temporal lobe epilepsy (TLE) and identify measures…
Case A 48-year-old woman developed painless bilateral acute visual loss with a progressive visual field defect over 2 weeks. At the initial visit, her best-corrected…
When the COVID-19 pandemic reduced opportunities for inperson learning for students, residents and fellows, many neurologists turned to online learning modalities such as podcasts, webinars…
Background and Objectives To expand the clinical knowledge of GPAA1-related glycosylphosphatidylinositol (GPI) deficiency. Methods An international case series of 7 patients with biallelic GPAA1 variants…
Objective To assess the association of regional grey matter atrophy with dementia risk in a general older Japanese population. Methods We followed 1158 dementia-free Japanese…
Introduction The effect of disease-modifying therapies (DMT) on vaccine responses is largely unknown. Understanding the development of protective immunity is of paramount importance to fight…
English
العربية
简体中文
Nederlands
Français
Deutsch
Italiano
Português
Русский
Español